Clinical Trials Sponsored by Neovasc Inc.

Total 35388 results

Neovasc Inc.

Active, not recruiting

Tiara™ Transcatheter Mitral Valve Replacement Study (TIARA-II)

Mitral Valve Regurgitation

Spain, Italy, Germany, Israel, Netherlands, United Kingdom
Neovasc Inc.

Completed

Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations. (GAAME)

Angioplasty

United States, Canada, Netherlands
Neovasc Inc.

Active, not recruiting

Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System (TIARA-I)

Mitral Valve Regurgitation

United States, Canada, Belgium
Neovasc Inc.

Completed

Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA (COSIRA)

Refractory Angina

United Kingdom, Canada, Belgium, Denmark, Netherlands, Sweden
Neovasc Inc.
Shockwave Medical, Inc.

Recruiting

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II (COSIRA-II)

Refractory Angina

United States, Canada
Neovasc Inc.
Shockwave Medical, Inc.

Active, not recruiting

REDUCER-I: An Observational Study of the Neovasc Reducer™ System

Angina Pectoris | Chronic Stable Angina | Angina Pectoris, Stable

Netherlands, Spain, United Kingdom, Germany, Italy, Switzerland, Belgium, France, Austria
Neovacs

Withdrawn

Study of IFN-K in Dermatomyositis

Dermatomyositis

Italy, France, Switzerland, Germany
Neovacs

Completed

Safety of IFNa Kinoid in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Switzerland, France, Germany, Croatia, Belgium, Bulgaria
Neovacs

Completed

Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients

Crohn's Disease

Germany, Belgium, France, Romania, Bulgaria, Croatia, Czech Republic, Hungary, Netherlands
Neovacs

Completed

Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists

Rheumatoid Arthritis

Belgium, France, Bulgaria, Argentina, Croatia, Chile, Romania
Neovacs

Terminated

Phase IIb Study of IFN-K in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Germany, Italy, Taiwan, Thailand, Mexico, Argentina, Belgium, France, Switzerland, Georgia, Philippines, Russian Federation, Korea, Republic of, Croatia, Peru, Poland, Colombia, Chile, Tunisia, Moldova, Republic of
Neovacs

Completed

Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium, Hungary, Georgia, Moldova, Republic of, Lebanon, Macedonia, The Former Yugoslav Republic of, Poland, Russian Federation, Serbia, Ukraine
Neovacs

Completed

Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease

Crohn's Disease

Switzerland, South Africa
Johannes Gutenberg University Mainz
Neovasc Inc.

Recruiting

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina (COSIMA)

Refractory Angina | Coronary Microvascular Disease

Germany
Tel-Aviv Sourasky Medical Center
Neovasc Inc.

Recruiting

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization (Reducer)

Refractory Angina

Israel
Endovasc

Unknown

Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease

Peripheral Vascular Disease

United States
NeuroVasc Technologies

Recruiting

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke (ENVI RCT)

Acute Ischemic Stroke

United States
Ascopharm Groupe Novasco

Completed

Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer (PA0903)

Root Canal Obturation

France, United Kingdom
Northwest Health
Neolac Inc dba Medolac Laboratories

Enrolling by invitation

Novel Human Milk Based Human Milk Fortifier (MHMHMF)

Infant, Premature, Diseases

United States
Augusta University
Neolac Inc dba Medolac Laboratories

Unknown

Growth and Nutritional Status of Very Low Birth Weight Infants Fed a High Protein Exclusive Human Milk Diet (MedolacHMF)

Premature Infant | Breast Milk Expression

United States
Neolac Inc dba Medolac Laboratories
University of Louisville

Completed

Donor Human Milk in Neonatal Abstinence Syndrome (DHM&NAS)

Neonatal Abstinence Syndrome

United States
Pharnext SA
Ascopharm Groupe Novasco

Completed

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) (PLEODIAL-I)

Alzheimer Disease

France
Pharnext SA
Ascopharm Groupe Novasco

Completed

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion (PLEODIAL-II)

Alzheimer Disease

France
Ascopharm Groupe Novasco
Groupe Hospitalier Pitie-Salpetriere; Medco Health Solutions, Inc.

Completed

Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction. (DOSAPI)

Anti Platelet Effects

France
Evasc Medical Systems Corp.

Withdrawn

Canadian eCLIPs™ Safety and Feasibility Study Protocol (CESIS)

Intracranial Aneurysms

Canada
Evasc Medical Systems Corp.

Withdrawn

An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms

Aneurysm, Intracranial
Ascopharm Groupe Novasco
Ramsay Générale de Santé

Unknown

ACL Versus ALL + ACL Study

Anterior Cruciate Ligament Injury | Ligament Rupture

France
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Ovarian Cancer

Russian Federation
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Epithelial Ovarian Cancer | Non-small Cell Lung Cancer

Russian Federation
Shanghai 10th People's Hospital
Hangzhou NeoVax Biotechnology Co. LTD

Recruiting

Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

Glioma, Malignant | Antigen-specific Vaccines | Individualized Treatment

China
Evasc Medical Systems Corp.
European Cardiovascular Research Center

Recruiting

French eCLIPs™ Efficacy and Safety Investigation (EESIS-Fr)

Intracranial Aneurysm

France
Evasc Medical Systems Corp.
Radboud University Medical Center

Terminated

European eCLIPS™ Safety, Feasibility and Efficacy Study (EESIS)

Intracranial Aneurysm | Saccular Aneurysm

Netherlands, Denmark, Germany
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Ascopharm Groupe Novasco
AscoPharm is conducting the study under the responsibility of SEPTODONT

Completed

Efficacy and the Safety Study of RD94 in Patients With Endodontic Care (RD94)

Tooth Injury

France
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Recruiting

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

United States
Novan, Inc.
Synteract, Inc.; Therapeutics, Inc.

Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study (B-SIMPLE4)

Molluscum Contagiosum

United States
OBELAB, Inc.
Helptrial Inc.

Not yet recruiting

Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Acute Ischemic Stroke Patients

Korea, Republic of
Athersys, Inc
Medpace, Inc.

Recruiting

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Ischemic Stroke

United States, Taiwan

Clinical Trials Sponsored by Neovasc Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations